These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20883965)

  • 41. Tuberculosis control in New York City--a changing landscape.
    Macaraig M; Burzynski J; Varma JK
    N Engl J Med; 2014 Jun; 370(25):2362-5. PubMed ID: 24941176
    [No Abstract]   [Full Text] [Related]  

  • 42. Impact of HIV prevention programs on drug users in Malaysia.
    Kamarulzaman A
    J Acquir Immune Defic Syndr; 2009 Nov; 52 Suppl 1():S17-9. PubMed ID: 19858930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unsafe medical injections and HIV transmission in India.
    Tahir M; Sharma SK; Smith-Rohrberg D
    Lancet Infect Dis; 2007 Mar; 7(3):178-9. PubMed ID: 17317597
    [No Abstract]   [Full Text] [Related]  

  • 44. The UK HIV/AIDS control: inappropriate measures for home and abroad.
    Choudhury CR
    Natl Med J India; 2004; 17(5):283-4. PubMed ID: 15638321
    [No Abstract]   [Full Text] [Related]  

  • 45. Sustaining HIV prevention: HIV testing in health care settings.
    Fenton KA
    Top HIV Med; 2007; 15(5):146-9. PubMed ID: 18073449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Action pledged by religious leaders at global HIV summit.
    Morris K
    Lancet Infect Dis; 2010 May; 10(5):299. PubMed ID: 20422764
    [No Abstract]   [Full Text] [Related]  

  • 47. Policy watch. More of the same?
    Gebbie KM
    AIDS Read; 2004 Jul; 14(7):350-1. PubMed ID: 15281170
    [No Abstract]   [Full Text] [Related]  

  • 48. Youth and HIV/AIDS: an American agenda. A report to the President. Executive summary of a report prepared by the Office of National AIDS Policy.
    Pediatr AIDS HIV Infect; 1996 Oct; 7(5):307-9. PubMed ID: 11361488
    [No Abstract]   [Full Text] [Related]  

  • 49. CDC seeking to cut U.S. HIV infections in half.
    J Calif Dent Assoc; 2001 Apr; 29(4):269. PubMed ID: 11346996
    [No Abstract]   [Full Text] [Related]  

  • 50. HIV postexposure prophylaxis registry closing.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Mar; 48(9):194-5. PubMed ID: 10215492
    [No Abstract]   [Full Text] [Related]  

  • 51. Introducing the HIV/AIDS roundtable and its seven commentaries.
    Freeman P
    J Public Health Policy; 2012 Aug; 33(3):287-9. PubMed ID: 22895497
    [No Abstract]   [Full Text] [Related]  

  • 52. Infectious disease challenges in the 1990's.
    Opal SM
    Med Health R I; 1996 Mar; 79(3):100-9. PubMed ID: 8901290
    [No Abstract]   [Full Text] [Related]  

  • 53. Plague. The AIDS epidemic offers a host of lessons in stemming the next scourge.
    Friedman E
    Health Forum J; 2001; 44(6):5-7. PubMed ID: 11725436
    [No Abstract]   [Full Text] [Related]  

  • 54. Communicable disease policy development in response to changing European political frontiers in Finland, Norway and Sweden.
    Bernitz BK
    Scand J Public Health; 2008 Nov; 36(8):875-8. PubMed ID: 19004906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. D for diagnosis and E for everything else.
    De Cock KM
    Bull World Health Organ; 2006 Oct; 84(10):774-5. PubMed ID: 17128355
    [No Abstract]   [Full Text] [Related]  

  • 56. An assessment of the Pakistan national HIV/AIDS strategy for sex workers.
    Hanif HM
    J Infect Public Health; 2012 Apr; 5(2):215-6. PubMed ID: 22541273
    [No Abstract]   [Full Text] [Related]  

  • 57. The nurse and the HIV patient--what should the healthcare policy be?
    Monteith SK
    Revolution; 1993; 3(4):12-6, 81. PubMed ID: 8193776
    [No Abstract]   [Full Text] [Related]  

  • 58. Economic evaluations of HIV prevention in rich countries and the need to focus on the aging of the HIV-positive population.
    Brent RJ; Brennan M; Karpiak SE
    Curr Opin HIV AIDS; 2010 May; 5(3):255-60. PubMed ID: 20539083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Developing and evaluating comprehensive HIV infection control strategies: issues and challenges.
    DeGruttola V; Smith DM; Little SJ; Miller V
    Clin Infect Dis; 2010 May; 50 Suppl 3(Suppl 3):S102-7. PubMed ID: 20397937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical costs averted by HIV prevention efforts in the United States, 1991-2006.
    Farnham PG; Holtgrave DR; Sansom SL; Hall HI
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):565-7. PubMed ID: 20647830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.